Literature DB >> 31227652

Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals?

Elizabeth Kurudamannil George1, P Hemachandra Reddy2,1,3,4,5,6,7.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory loss and multiple cognitive impairments. Current healthcare costs for over 50 million people afflicted with AD are about $818 million and are projected to be $2 billion by 2050. Unfortunately, there are no drugs currently available that can delay and/or prevent the progression of disease in elderly individuals and in AD patients. Loss of synapses and synaptic damage are largely correlated with cognitive decline in AD patients. Women are at a higher lifetime risk of developing AD encompassing two-thirds of the total AD afflicted population. Only about 1-2% of total AD patients can be explained by genetic mutations in APP, PS1, and PS2 genes. Several risk factors have been identified, such as Apolipoprotein E4 genotype, type 2 diabetes, traumatic brain injury, depression, and hormonal imbalance, are reported to be associated with late-onset AD. Strong evidence reveals that antioxidant enriched diets and regular exercise reduces toxic radicals, enhances mitochondrial function and synaptic activity, and improves cognitive function in elderly populations. Current available data on the use of antioxidants in mouse models of AD and antioxidant(s) supplements in diets of elderly individuals were investigated. The use of antioxidants in randomized clinical trials in AD patients was also critically assessed. Based on our survey of current literature and findings, we cautiously conclude that healthy diets, regular exercise, and improved lifestyle can delay dementia progression and reduce the risk of AD in elderly individuals and reverse subjects with mild cognitive impairment to a non-demented state.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-beta; antioxidant enriched diet; healthcare cost; healthy diets; mitochondria; phosphorylated tau; reactive oxygen species; regular exercise

Year:  2019        PMID: 31227652     DOI: 10.3233/JAD-190232

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

1.  Cross talk mechanisms of aerobic exercise training on obesity, type 2 diabetes, and Alzheimer's disease: the role of insulin resistance.

Authors:  Ricardo Augusto Leoni De Sousa; Caíque Olegário Diniz de Magalhães; Isabella Rocha Dias; Lucas Renan Sena de Oliveira; Alex Cleber Improta-Caria; Ricardo Cardoso Cassilhas
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-07       Impact factor: 1.712

2.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

3.  Dietary Diversity Is Associated With Memory Status in Chinese Adults: A Prospective Study.

Authors:  Jian Zhang; Ai Zhao; Wei Wu; Chenlu Yang; Zhongxia Ren; Meichen Wang; Peiyu Wang; Yumei Zhang
Journal:  Front Aging Neurosci       Date:  2020-09-02       Impact factor: 5.750

Review 4.  Physical exercise protocols in animal models of Alzheimer's disease: a systematic review.

Authors:  Ricardo Augusto Leoni De Sousa; Cíntia Maria Rodrigues; Bruno Ferreira Mendes; Alex Cleber Improta-Caria; Marco Fabrício Dias Peixoto; Ricardo Cardoso Cassilhas
Journal:  Metab Brain Dis       Date:  2020-10-23       Impact factor: 3.584

Review 5.  Defective mitophagy in Alzheimer's disease.

Authors:  Jangampalli Adi Pradeepkiran; P Hemachandra Reddy
Journal:  Ageing Res Rev       Date:  2020-10-03       Impact factor: 10.895

Review 6.  Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.

Authors:  Pradeepkiran Jangampalli Adi; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-04-30       Impact factor: 6.633

Review 7.  Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria.

Authors:  Albin John; P Hemachandra Reddy
Journal:  Ageing Res Rev       Date:  2020-11-04       Impact factor: 10.895

8.  Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease.

Authors:  Arubala P Reddy; Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Lloyd E Bunquin; Xiangling Yin; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2021-05-28       Impact factor: 6.150

9.  The Comparisons of Physical Functional Performances between Older Adults with and without Regular Physical Activity in Two Different Living Settings.

Authors:  I-Fang Cheng; Li-Chieh Kuo; Yi-Jung Tsai; Fong-Chin Su
Journal:  Int J Environ Res Public Health       Date:  2021-03-30       Impact factor: 3.390

Review 10.  Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches.

Authors:  Kiran Kumar Siddappaji; Shubha Gopal
Journal:  AIMS Neurosci       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.